AJP - Regulatory, Integrative and Comparative Physiology, Vol 262, Issue 1 85-R89, Copyright © 1992 by American Physiological Society

ARTICLES

Endothelin-1 potentiation of angiotensin II stimulation of aldosterone production

E. N. Cozza, S. Chiou and C. E. Gomez-Sanchez
Department of Internal Medicine, University of South Florida Health Sciences Center, Tampa.

Endothelin-1 (ET-1) binds to specific receptors in cultured bovine adrenal glomerulosa cells and stimulates aldosterone secretion with a 50% effective concentration (EC50) of 300 +/- 80 pM (mean +/- SE). The relative stimulatory potency for ET-1 is significantly less than that of angiotensin II (ANG II). The incubation of calf zona glomerulosa cells in primary culture with ET-1 and ANG II resulted in a significant potentiation of ANG II effect on aldosterone secretion. The EC50 of ET-1 potentiation of ANG II-induced stimulation of aldosterone secretion was 40 +/- 5 pM (mean +/- SE, n = 4), which is lower than the EC50 for ET-1 stimulation of aldosterone secretion. Adrenocorticotropic hormone (ACTH) stimulation of aldosterone secretion, but not that of potassium, was also potentiated by ET-1, but to a lesser degree. ET-1 and ET-1-mediated potentiation of ANG II-stimulated aldosterone biosynthesis increased both the early and late pathways of aldosterone biosynthesis, but the potentiation was greater for the early pathway. Preincubation with ET-1 for at least 15 min, followed by extensive washing to remove bound ET-1, also resulted in persistent potentiation of ANG II-mediated aldosterone secretion. ET-2, sarafotoxin, and vasoactive intestinal contractor potentiation of ANG II action were very similar to that of ET-1. ET-3 and Big-ET-1 potentiated ANG II stimulation only at the highest doses tested and the proendothelin-(110-130) fragment was inactive. ET-1 potentiation of ANG II action is likely to be mediated through an ETB receptor subtype.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438. [Abstract] [Full Text] [PDF]

				G. Mazzocchi, L. K. Malendowicz, F. G. Musajo, G. Gottardo, A. Markowska, and G. G. Nussdorfer Role of endothelins in regulation of vascular tone in the in situ perfused rat adrenals Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E1 - E5. [Abstract] [Full Text] [PDF]

				S. Rajagopalan, J. B. Laursen, A. Borthayre, S. Kurz, J. Keiser, S. Haleen, A. Giaid, and D. G. Harrison \E Role for Endothelin-1 in Angiotensin II– Mediated Hypertension Hypertension, July 1, 1997; 30(1): 29 - 34. [Abstract] [Full Text]

				A. S. Belloni, G. P. Rossi, P. G. Andreis, G. Neri, G. Albertin, A. C. Pessina, and G. G. Nussdorfer Endothelin Adrenocortical Secretagogue Effect Is Mediated by the B Receptor in Rats Hypertension, May 1, 1996; 27(5): 1153 - 1159. [Abstract] [Full Text]

				E. R. Levin Endothelins N. Engl. J. Med., August 10, 1995; 333(6): 356 - 363. [Full Text] [PDF]

				G. Rossi, A. S. Belloni, G. Albertin, L. Zanin, M. A. Biasolo, G. G. Nussdorfer, G. Palu, and A. C. Pessina Endothelin-1 and Its Receptors A and B in Human Aldosterone-Producing Adenomas Hypertension, April 1, 1995; 25(4): 842 - 847. [Abstract] [Full Text]